BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29506630)

  • 1. Human podocytes responses to alternatively spliced Extra domain A Fibronectin in culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):45-52. PubMed ID: 29506630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ1-mediated PI3K/Akt and p38 MAP kinase dependent alternative splicing of fibronectin extra domain A in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):127-135. PubMed ID: 29729706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ1-mediated expression and alternative splicing of Fibronectin Extra Domain A in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):17-24. PubMed ID: 29506626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCN3, a key matricellular protein, distinctly inhibits TGFβ1-mediated Smad1/5/8 signalling in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):5-10. PubMed ID: 29506624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Regulation of TGFβ1 Induced Fibronectin EDA Exon Alternative Splicing in Human Renal Proximal Tubule Epithelial Cells.
    Phanish MK; Heidebrecht F; Nabi ME; Shah N; Niculescu-Duvaz I; Dockrell ME
    J Cell Physiol; 2015 Feb; 230(2):286-95. PubMed ID: 24962218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway.
    White ES; Sagana RL; Booth AJ; Yan M; Cornett AM; Bloomheart CA; Tsui JL; Wilke CA; Moore BB; Ritzenthaler JD; Roman J; Muro AF
    Exp Cell Res; 2010 Oct; 316(16):2644-53. PubMed ID: 20615404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatively spliced isoforms of fibronectin in immune-mediated glomerulosclerosis: the role of TGFbeta and IL-4.
    Baelde HJ; Eikmans M; van Vliet AI; Bergijk EC; de Heer E; Bruijn JA
    J Pathol; 2004 Nov; 204(3):248-57. PubMed ID: 15372454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta1 regulates fibronectin isoform expression and splicing factor SRp40 expression during ATDC5 chondrogenic maturation.
    Han F; Gilbert JR; Harrison G; Adams CS; Freeman T; Tao Z; Zaka R; Liang H; Williams C; Tuan RS; Norton PA; Hickok NJ
    Exp Cell Res; 2007 May; 313(8):1518-32. PubMed ID: 17391668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Fibronectin Containing Extra Domain A Causes Insulin Resistance via Toll-like Receptor 4.
    Rajak S; Hussain Y; Singh K; Tiwari S; Ahmad B; Bharti S; Prakash P
    Sci Rep; 2020 Jun; 10(1):9102. PubMed ID: 32499562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.
    Zoppi N; Ritelli M; Colombi M
    Biochim Biophys Acta; 2012 Oct; 1820(10):1576-87. PubMed ID: 22705941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired splicing of fibronectin is associated with thoracic aortic aneurysm formation in patients with bicuspid aortic valve.
    Paloschi V; Kurtovic S; Folkersen L; Gomez D; Wågsäter D; Roy J; Petrini J; Eriksson MJ; Caidahl K; Hamsten A; Liska J; Michel JB; Franco-Cereceda A; Eriksson P
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):691-7. PubMed ID: 21148425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRISPR/Cas system inhibited the pro-oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells.
    Wang HC; Yang Y; Xu SY; Peng J; Jiang JH; Li CY
    Oral Dis; 2015 Jul; 21(5):608-18. PubMed ID: 25684411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay of fibronectin functionalization and TGF-β1 presence on fibroblast proliferation, differentiation and migration in 3D matrices.
    Sapudom J; Rubner S; Martin S; Thoenes S; Anderegg U; Pompe T
    Biomater Sci; 2015 Sep; 3(9):1291-301. PubMed ID: 26230292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.
    Doddapattar P; Jain M; Dhanesha N; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):500-508. PubMed ID: 29326316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis.
    Booth AJ; Wood SC; Cornett AM; Dreffs AA; Lu G; Muro AF; White ES; Bishop DK
    J Pathol; 2012 Mar; 226(4):609-18. PubMed ID: 21960174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment.
    Manabe R; Ohe N; Maeda T; Fukuda T; Sekiguchi K
    J Cell Biol; 1997 Oct; 139(1):295-307. PubMed ID: 9314547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine.
    Julier Z; Martino MM; de Titta A; Jeanbart L; Hubbell JA
    Sci Rep; 2015 Feb; 5():8569. PubMed ID: 25708982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatively-spliced extra domain A of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice.
    Khan MM; Gandhi C; Chauhan N; Stevens JW; Motto DG; Lentz SR; Chauhan AK
    Stroke; 2012 May; 43(5):1376-82. PubMed ID: 22363055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternatively spliced EDA segment regulates fibronectin-dependent cell cycle progression and mitogenic signal transduction.
    Manabe R; Oh-e N; Sekiguchi K
    J Biol Chem; 1999 Feb; 274(9):5919-24. PubMed ID: 10026216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.